Form 4: Astera Labs CEO Jitendra Mohan Executes Stock Sale

Astera Labs CEO Jitendra Mohan sold 2,967 shares of common stock on April 15, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.

Summary

• Jitendra Mohan, CEO of Astera Labs, Inc., sold a total of 2,967 shares of common stock.
• The transactions occurred on April 15, 2026.
• The sales were executed in two batches: 2,767 shares at a weighted average price of $174.5682 and 200 shares at $175.03.
• The sales were conducted automatically under a Rule 10b5-1 trading plan adopted on December 1, 2025.
• Following these transactions, the reporting person retains significant indirect ownership through various trusts and direct ownership of 1,452,739 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed under a pre-arranged plan and represents a small fraction of the CEO's total holdings.

Positives

• The sale was conducted via a pre-planned Rule 10b5-1 trading plan, which is a standard mechanism for executives to sell shares without triggering insider trading concerns.

Negatives

• The sale represents a reduction in the CEO's direct and indirect holdings, which may be perceived as a lack of long-term confidence by some market participants.

Risks

• Continued reliance on Rule 10b5-1 plans for liquidity may lead to periodic selling pressure on the stock.

Future Outlook

No specific forward-looking guidance regarding company operations was provided in this filing.

Industry Context

StockSavvy.ai notes that executive stock sales via 10b5-1 plans are common in the semiconductor and high-growth tech sectors, often serving as routine liquidity events rather than signals of operational distress.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate executives to manage equity compensation and personal financial planning while maintaining regulatory compliance.

Stakeholder Impact

• Shareholders should note the ongoing reduction in insider holdings, though the volume is relatively minor compared to total shares owned.

Next Steps

• Continued monitoring of future Form 4 filings for further insider activity.

Key Dates

Keywords

Astera Labs, ALAB, Insider Trading, Form 4, Jitendra Mohan, Stock Sale, Rule 10b5-1